BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND SET, I2PP2A, 6418, ENSG00000119335, TAF-IBETA, PHAPII, IGAAD, 2PP2A
4393 results:

  • 1. [Computer-vision-based artificial intelligence for detection and recognition of instruments and organs during radical laparoscopic gastrectomy for gastric cancer: a multicenter study].
    Zhang KC; Qiao Z; Yang L; Zhang T; Liu FL; Sun DC; Xie TY; Guo L; Lu CR
    Zhonghua Wei Chang Wai Ke Za Zhi; 2024 May; 27(5):464-470. PubMed ID: 38778686
    [No Abstract]    [Full Text] [Related]  

  • 2. Development of an individualized model for predicting postoperative delirium in elderly patients with hepatocellular carcinoma.
    Yan M; Lin Z; Zheng H; Lai J; Liu Y; Lin Z
    Sci Rep; 2024 May; 14(1):11716. PubMed ID: 38777824
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Survival Predictive Nomograms for Non-Surgical Brain Metastases Patients From Non-Small Cell Lung cancer Receiving Radiotherapy: A Population-Based Study.
    Li P; Luo J; Zheng Z; Meng L; Zhang A; Cao W; Gong X
    Cancer Control; 2024; 31():10732748241255212. PubMed ID: 38769789
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. A multi-parametric prognostic model based on clinicopathologic features: vessels encapsulating tumor clusters and hepatic plates predict overall survival in hepatocellular carcinoma patients.
    Xiong SP; Wang CH; Zhang MF; Yang X; Yun JP; Liu LL
    J Transl Med; 2024 May; 22(1):472. PubMed ID: 38762511
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Construction of a prognostic model for extensive-stage small cell lung cancer patients undergoing immune therapy in northernmost China and prediction of treatment efficacy based on response status at different time points.
    Dang J; Xu G; Guo G; Zhang H; Shang L
    J Cancer Res Clin Oncol; 2024 May; 150(5):255. PubMed ID: 38750370
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. PLAG1 interacts with GPX4 to conquer vulnerability to sorafenib induced ferroptosis through a PVT1/miR-195-5p axis-dependent manner in hepatocellular carcinoma.
    Li J; Li Y; Wang D; Liao R; Wu Z
    J Exp Clin Cancer Res; 2024 May; 43(1):143. PubMed ID: 38745179
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Early detection and prognosis evaluation for hepatocellular carcinoma by circulating tumour DNA methylation: A multicentre cohort study.
    Guo DZ; Huang A; Wang YC; Zhou S; Wang H; Xing XL; Zhang SY; Cheng JW; Xie KH; Yang QC; Ma CC; Li Q; Chen Y; Su ZX; Fan J; Liu R; Liu XL; Zhou J; Yang XR
    Clin Transl Med; 2024 May; 14(5):e1652. PubMed ID: 38741204
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Development of a machine learning-based model to predict prognosis of alpha-fetoprotein-positive hepatocellular carcinoma.
    Dong B; Zhang H; Duan Y; Yao S; Chen Y; Zhang C
    J Transl Med; 2024 May; 22(1):455. PubMed ID: 38741163
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. High expression of SRSF1 facilitates osteosarcoma progression and unveils its potential mechanisms.
    Li S; Huang X; Zheng S; Zhang W; Liu F; Cao Q
    BMC Cancer; 2024 May; 24(1):580. PubMed ID: 38735973
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Phenotyping Hepatic Immune-Related Adverse Events in the setting of Immune Checkpoint Inhibitor Therapy.
    Feldman TC; Kaplan DE; Lin A; La J; Lee JSH; Aljehani M; Tuck DP; Brophy MT; Fillmore NR; Do NV
    JCO Clin Cancer Inform; 2024 May; 8():e2300159. PubMed ID: 38728613
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. RRP8, associated with immune infiltration, is a prospective therapeutic target in hepatocellular carcinoma.
    You K; Du X; Zhao Y; Wen F; Lu Z; Fan H
    J Cancer Res Clin Oncol; 2024 May; 150(5):245. PubMed ID: 38722372
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Design and synthesis of novel JNK inhibitors targeting liver pyruvate kinase for the treatment of non-alcoholic fatty liver disease and hepatocellular carcinoma.
    Iqbal S; Sebhaoui J; Ashraf S; Ozcan M; Kim W; Belmen B; Yeşilyurt G; Hanashalshahaby E; Zhang C; Uhlen M; Boren J; Turkez H; Mardinoglu A
    Bioorg Chem; 2024 Jun; 147():107425. PubMed ID: 38714117
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Role of CENPF and NDC80 in the rehabilitation nursing of hepatocellular carcinoma and cirrhosis: An observational study.
    Jia W; Wu Q; Li R; Hou S; Kang C
    Medicine (Baltimore); 2024 May; 103(18):e37984. PubMed ID: 38701255
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Comprehensive pan-cancer analysis of YBX family reveals YBX2 as a potential biomarker in liver cancer.
    Yuan Z; Li B; Liao W; Kang D; Deng X; Tang H; Xie J; Hu D; Chen A
    Front Immunol; 2024; 15():1382520. PubMed ID: 38698857
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Progressive sarcopenia and myosteatosis predict prognosis of advanced HCC patients treated with immune checkpoint inhibitors.
    Liu M; Jin Q; Wang H; Li Y
    Front Immunol; 2024; 15():1396927. PubMed ID: 38690276
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Quasi-intrinsic thiobase derivatives as potential targeted photosensitizers in two-photon photodynamic therapy.
    Cui X; Fan J; Lyu Y; Zhou X; Meng Q; Zhang C
    Spectrochim Acta A Mol Biomol Spectrosc; 2024 Aug; 316():124311. PubMed ID: 38663131
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Autonomous circadian rhythms in the human hepatocyte regulate hepatic drug metabolism and inflammatory responses.
    March S; Nerurkar N; Jain A; Andrus L; Kim D; Whittaker CA; Tan EKW; Thiberge S; Fleming HE; Mancio-Silva L; Rice CM; Bhatia SN
    Sci Adv; 2024 Apr; 10(17):eadm9281. PubMed ID: 38657074
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. The fatty liver disease-causing protein PNPLA3-I148M alters lipid droplet-Golgi dynamics.
    Sherman DJ; Liu L; Mamrosh JL; Xie J; Ferbas J; Lomenick B; Ladinsky MS; Verma R; Rulifson IC; Deshaies RJ
    Proc Natl Acad Sci U S A; 2024 Apr; 121(18):e2318619121. PubMed ID: 38657050
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Efficacy and safety of tislelizumab plus lenvatinib as first-line treatment in patients with unresectable hepatocellular carcinoma: a multicenter, single-arm, phase 2 trial.
    Xu L; Chen J; Liu C; Song X; Zhang Y; Zhao H; Yan S; Jia W; Wu Z; Guo Y; Yang J; Gong W; Ma Y; Yang X; Gao Z; Zhang N; Zheng X; Li M; Su D; Chen M
    BMC Med; 2024 Apr; 22(1):172. PubMed ID: 38650037
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Single-cell analysis revealed a potential role of T-cell exhaustion in colorectal cancer with liver metastasis.
    Ling T; Zhang C; Liu Y; Jiang C; Gu L
    J Cell Mol Med; 2024 Apr; 28(8):e18341. PubMed ID: 38647235
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 220.